ADRO
Aduro

2,522
Loading...
Loading...
Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
96

Frequently Asked Questions

What is Market Cap of Aduro Biotech Inc?
What is the 52-week high for Aduro Biotech Inc?
What is the 52-week low for Aduro Biotech Inc?
What is Aduro Biotech Inc stock price today?
What was Aduro Biotech Inc stock price yesterday?
What is the PE ratio of Aduro Biotech Inc?
What is the Price-to-Book ratio of Aduro Biotech Inc?
What is Aduro Biotech Inc's EBITDA?
What is the 50-day moving average of Aduro Biotech Inc?
How many employess does Aduro Biotech Inc has?

Latest ADRO News

View
No ADRO news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.